Summary:
A Randomized, Double-blind, Placebo-controlled Trial to Assess the
Efficacy and Safety of AXS-05 for the Treatment of Agitation in
Subjects with Dementia of the Alzheimer’s Type
Qualified Participants Must:
• Male or female outpatients, 65 to 90 years of age
•
Diagnosis of probable Alzheimers disease
Qualified Participants May Receive:
Compensation for time and travel